Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

2 December 2022 (15:30 - 15:37)
Organised by:
Congress Presentation Part of: Pharmacology and Pharmacotherapy Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

ESC 365 is supported by

ESC 365 is supported by